Medisynth Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 20-12-2024
- Paid Up Capital ₹ 2.00 M
as on 20-12-2024
- Company Age 41 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.60 Cr
as on 20-12-2024
- Satisfied Charges ₹ 7.23 Cr
as on 20-12-2024
- Revenue 14.25%
(FY 2022)
- Profit 83.29%
(FY 2022)
- Ebitda 45.08%
(FY 2022)
- Net Worth 24.99%
(FY 2022)
- Total Assets 20.39%
(FY 2022)
About Medisynth Chemicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹9.60 Cr. The company has closed loans amounting to ₹7.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jayant Vaknalli, Sunila Vaknalli, Riti Vaknalli, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH1983PTC029252
- Company No.
029252
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 1983
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medisynth Chemicals Pvt Ltd offer?
Medisynth Chemicals Pvt Ltd offers a wide range of products and services, including Homeopathic Drugs, Homeopathic Ointment, Fitness Supplements, Energy Supplement, Homoeopathic Drops, Homoeopathic Syrup, Ayurvedic Medicine, Herbal Stress Relief Capsules Tablets, Nasal Drops, Sodium Chloride Nasal Drops.
Who are the key members and board of directors at Medisynth Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Vaknalli  | Director | 30-Aug-2018 | Current |
| Sunila Vaknalli | Director | 30-Aug-2018 | Current |
| Riti Vaknalli | Director | 04-Nov-2019 | Current |
| Nihar Vaknalli | Director | 01-Mar-2014 | Current |
Financial Performance of Medisynth Chemicals.
Medisynth Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 14.25% increase. The company also saw a substantial improvement in profitability, with a 83.29% increase in profit. The company's net worth Soared by an impressive increase of 24.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisynth Chemicals?
In 2021, Medisynth Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisynth Naturals Private LimitedActive 38 years 5 monthsJayant Vaknalli, Sunila Vaknalli and 2 more are mutual person
New Era Homoeopathic Pharmacy LlpActive 8 years 8 monthsJayant Vaknalli and Sunila Vaknalli are mutual person
- Beck And Koll Laboratories Private LimitedActive 50 years 2 months
Jayant Vaknalli and Sunila Vaknalli are mutual person
- Vac Pharmaceuticals Pvt. Ltd.Active 38 years 5 months
Jayant Vaknalli and Sunila Vaknalli are mutual person
- Vcnally Sales Private LimitedActive 49 years 22 days
Jayant Vaknalli and Sunila Vaknalli are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 05 Jun 2014 | ₹4.80 Cr | Open |
Axis Bank Limited Creation Date: 29 Nov 2012 | ₹4.80 Cr | Open |
Aditya Birla Finance Limited Creation Date: 05 Dec 2014 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Medisynth Chemicals?
Unlock and access historical data on people associated with Medisynth Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisynth Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisynth Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
